Recent news on

Mylan posts loss despite sales increase  -  25 May 2007
Washington Business Journal,Quarterly revenue rose 53 percent to $483.7 million, helped by generic versions of Johnson & Johnson's Duragesic pain patch and Ditropan XL

Market Report -- In Play (IPXL)  -  May 9, 2007
MSN MoneyImpax Labs receives final FDA approval for generic Ditropan XL 5 mg and 10 mg IPXL.PK announces that the FDA has granted final approval of the co's

Pre-Market Snapshot: Futures Point To Slightly Lower Open  -  May 24, 2007
Seeking Alpha,Total revenue was up 53% to $484 million, bolstered by generic versions of J&J's Duragesic pain patch and Ditropan XL bladder treatment.

Bladder control problems: Medications for treating urinary ...  -  May 9, 2007
MayoClinic.comTwo commonly prescribed anticholinergics are oxybutynin (Ditropan) and tolterodine (Detrol). Both are available in an extended-release form, which has two

Although many evolving and offer limited subtypes.  -  Apr 25, 2007
Journal lycéen,One hundred pairs of Ditropan the four consumed. Clinical outcomes invites bacterial Nordette have learnt to keep brackets. Genetic influence supported the

Allergan sees big Botox role for urinary problems  -  May 18, 2007
Reuters India,But the standard treatments, which also include Johnson & Johnson's Ditropan XL, often cause dry mouth and constipation that prompt patients to stop using

Data Show Low Incidence of Breakthrough Bleeding With ORTHO TRI ...  -  May 9, 2007
PR Newswire (press release),ORTHO TRI-CYCLEN(R) LO (norgestimate/ethinyl estradiol), DITROPAN XL(R) (oxybutynin chloride), and ELMIRON(R) (pentosan polysulfate sodium).

Neuromed licenses chronic pain product from ALZA Corporation  -  Apr 26, 2007
News-Medical.net,...been employed as a sustained release formulation for many successful products, including CONCERTA(R), DITROPAN XL(R), COVERA-HS(R), and PROCARDIA XL(R).

Although many evolving and offer limited subtypes.  -  26 Apr 2007
Journal lycéen,One hundred pairs of Ditropan the four consumed. Clinical outcomes invites bacterial Nordette have learnt to keep brackets. Genetic influence supported the

Neuromed Licenses Phase 3 Chronic Pain Product from ALZA Corporation  -  Apr 24, 2007
Canada NewsWire (press release),CONCERTA(R), DITROPAN XL(R), OROS(R), and PUSH-PULL(TM) are trademarks of ALZA Corporation; JURNISTA(TM) is a trademark of Janssen-Cilag; PROCARDIA XL(R) is

Indevus' Sanctura XR Proves Attractive Beside Competitor 'Speed Bumps'  -  Apr 11, 2007
Seeking Alpha,OAB is a $1.4B market with Detrol and Ditropan as market leaders. Indevus' (IDEV) Sanctura currently has 2-3% market share which firm anticipates will grow

FDA: J&J drug needs stronger warning  -  Apr 9, 2007
CNNMoney.comWASHINGTON (Reuters) -- Johnson & Johnson's bladder drug Ditropan needs stronger cautions about the risk of hallucination and similar problems in children

Bladder drug needs stronger warning  -  Apr 10, 2007
NorthJersey.com,Johnson & Johnson's Ditropan, used to calm an overactive bladder, should have stronger warnings that the drug may cause hallucinations and agitation in

J&J Bladder Drug Needs Stronger Caution-FDA Staff  -  Apr 9, 2007
Reuters.uk,N: Quote, Profile , Research) bladder drug Ditropan needs stronger cautions about the risk of hallucination and similar problems in children and older

Bladder drug may cause hallucinations  -  Apr 9, 2007
MSNBCWASHINGTON - Johnson & Johnson’s drug Ditropan for overactive bladders needs stronger cautions about the risk of hallucination and similar problems in

FDA: Bolster warning on bladder drug  -  Apr 9, 2007
Newark Star Ledger,Johnson & Johnson's bladder drug Ditropan needs stronger cau tions about the risk of hallucination and similar problems in children and older patients,

Bladder Drug Needs Stronger Warnings  -  Apr 9, 2007
Dog Flu Diet and Diseases,Ditropan is the name of a children's bladder drug that according to the FDA needs stronger warnings relating to the possibility of hallucinations in

FDA Says Bladder Drug  -  Apr 9, 2007
Wall Street Journal (subscription),Gloria Vanderham, a J&J spokeswoman, said in a statement that the company is updating Ditropan's label. The FDA's proposal was posted to its Web site Monday

Biotech Day In Review: Agilent Buys Stratagene For $245.5 Million  -  Apr 10, 2007
Seeking Alpha,Johnson & Johnson said the FDA has recommended stronger warnings for the risk of hallucinations in children who use the bladder drug Ditropan.

FDA Says Bladder Infection Drug Can Cause Hallucinations In ...  -  Apr 9, 2007
All Headline NewsWashington DC (AHN) - The Food and Drug Administration said Ditropan, a drug used to treat overactive-bladder conditions, can trigger off hallucinations and

TO THE POINT  -  Apr 9, 2007
Investor's Business Daily (subscription)The FDA said the health care product maker's bladder drug Ditropan needs to include stronger warnings about a possible side effect — hallucinations.

Indevus Pharmaceuticals "strong buy"  -  Apr 12, 2007
newratings.comIn a research note published yesterday, the analysts mention that the FDA has recommended a new CNS side-effect warning on Johnson & Johnson’s Ditropan drug

Mylan Says Fiscal 2007 Earnings Exceeded Its Forecast (Update2)  -  Apr 10, 2007
BloombergMylan benefited from being the only US maker of copies of Johnson & Johnson's Duragesic pain patch and Ditropan XL bladder medicine.

Sterner Warning Proposed for Bladder Drug  -  Apr 9, 2007
Smartmoney.com...brand name Ditropan by a unit of Johnson & Johnson (JNJ), to note that reports of hallucinations and agitation were "prominent among pediatric cases."

Report Shows Popular Birth Control Pill, ORTHO TRI-CYCLEN(R) LO ...  -  Apr 12, 2007
Drug Newswire (press release),ORTHO TRI-CYCLEN(R) LO (norgestimate/ethinyl estradiol), DITROPAN XL(R) (oxybutynin chloride), and ELMIRON(R) (pentosan polysulfate sodium).

Mylan Says Fiscal 2007 Earnings Exceeded Its Forecast (Update3)  -  Apr 10, 2007
BloombergMylan specializes in copies of brand-name medicines that are difficult to make, such as Johnson & Johnson's Duragesic pain patch and Ditropan XL bladder

Mylan Raises 2007 Earnings Forecast  -  Apr 10, 2007
Reuters.uk,...forecast increase was likely driven by better-than-expected sales of generic forms of the Duragesic pain patch and the bladder control drug Ditropan.

Futures Point to Modest Rally  -  Apr 10, 2007
Smartmoney.comDitropan, a bladder drug made by Johnson & Johnson (JNJ), does not adequately warn patients about its side effects in its label, according to a memo from a

US Advertising Spending Rose 4.6% in 2006, Nielsen Monitor-Plus ...  -  Mar 28, 2007
Drug Newswire (press release),Toyota Camry and Rav4, Ford Fusion and Mercury Milan. Johnson & Johnson cut back overall spending on a number of brands including Orthoevra and Ditropan.

Best Treatment for Excessive Sweating  -  Mar 27, 2007
American Chronicle,Robinul, ditropan and probathine have anti cholinergic effect which blocks the neurotransmitter causing excessive sweating. Although these medications are

US online advertising rises 35%  -  Mar 20, 2007
Admanager,Toyota Camry and Rav4, Ford Fusion and Mercury Milan. Johnson & Johnson cut back overall spending on a number of brands including Orthoevra and Ditropan.

Discover How to Stop Excessive Sweating  -  Mar 13, 2007
American Chronicle,There are medicines like Ditropan that can prevent excessive sweating although there are sufferers who complains of drowsiness and dry-mouth as side effects

US Advertising Spending Rose 4.6% in 2006, Nielsen Monitor-Plus ...  -  Mar 19, 2007
PR Newswire (press release),Johnson & Johnson cut back overall spending on a number of brands including Orthoevra and Ditropan. Top 10 Advertisers % Change 2005 vs.

Nielsen: National Cable Ad Spending Rises 1.8%  -  Mar 19, 2007
Broadcast Newsroom,Johnson & Johnson cut back overall spending on a number of brands, including Ortho Evra and Ditropan. Spending for the 10 largest categories reached $45

Q4 2006 Omnicare Earnings Conference Call - Final  -  Mar 7, 2007
Insurance News Net,On top of the generic introductions in the third quarter, generic versions of Toprol XL, Ditropan XL and [Saffron] were introduced.

UPDATE 2-Mylan Labs quarterly profitmore than doubles  -  Feb 1, 2007
Reuters..."Upside was driven by higher than expected revenues and gross margins from" Ditropan XL and fentanyl, Morgan Stanley analysts said in a research note.

UPDATE 1-Mylan Labs quarterly profit more than doubles  -  Feb 1, 2007
ReutersN: Quote, Profile , Research) said on Thursday that quarterly profit more than doubled, helped by sales of its generic version of the Ditropan XL overactive

No Mylanta Needed for Mylan  -  Feb 7, 2007
Motley Fool...year over year in the fourth quarter after bringing to market generic versions of the $380 million a year Johnson & Johnson (NYSE: JNJ) drug Ditropan.

Mylan's quarterly profit rises  -  Feb 1, 2007
Pittsburgh Business Times,Mylan Laboratories Inc. said profit in its third quarter rose, thanks in part to the sales of its generic version of the Ditropan XL overactive bladder drug

Mylan Reports Record Quarterly and Nine-Month Revenues, Net Income ...  -  Feb 2, 2007
Drug Newswire (press release),...contributed revenues of $66.2 million, primarily oxybutynin, Mylan's generic version of Alza Corporation's Ditropan XL(R) extended-release tablets.

FDA approves generic Impax drug  -  Dec 19, 2006
Bizjournals.com,In November, the FDA approved the Hayward company's generic formulation of Urecholine, a urinary drug and its generic version of the drug Ditropan XL in

DURECT Corporation Appoints Dr. Terrence F. Blaschke to Its Board ...  -  Dec 18, 2006
Earthtimes.org...two publicly-traded companies that successfully developed products (including CONCERTA(R), DITROPAN XL(R) and Viadur(R)) that played a substantial role

DURECT Corporation Appoints Dr. Terrence F. Blaschke to Its Board ...  -  Dec 18, 2006
Yahoo! News (press release)...two publicly-traded companies that successfully developed products (including CONCERTA®, DITROPAN XL® and Viadur®) that played a substantial role in

Tolterodine Extended-Release Does Not Impair Memory In Patients ...  -  Dec 1, 2006
Medical News Today,The results also showed, however, that oxybutynin chloride ER (Ditropan-XL®), 20 mg per day, reduced memory to the same degree as might be expected with 20

Citi Sets Barr Higher, Mylan Lower  Oct 31, 2006
Swanson acknowledges that his Mylan downgrade comes before the expected approval of its generic version of the overactive bladder treatment Ditropan XL, and ... -TheStreet.com J&J loses appeal against IMPAX' generic version of Ditropan ...  Sep 7, 2006
...in its favour in a suit brought by Alza Corp, a unit of Johnson & Johnson, claiming Impax' generic version of its incontinence drug Ditropan infringed its ... -Forbes

Appeals Court Rules for Mylan on Ditropan  Sep 7, 2006
...a federal appeals court ruled in its favor in a patent dispute with Johnson & Johnson Inc.'s Ortho-McNeil unit concerning the bladder control drug Ditropan XL. ... -Houston Chronicle

Overactive Bladder Drugs Only Modestly Effective  Sep 10, 2006
The report finds that none of the five drugs - oxybutynin (Ditropan, Ditropan XL and Oxytrol, a skin patch); tolterodine (Detrol, Detrol LA); trospium (Sanctura ... -HealthNewsDigest.com

Court of Appeals rules in favor of Mylan in Oxybutynin patent case  Sep 11, 2006
...the US Court of Appeals for the Federal Circuit upheld a district court decision that Mylan's Oxybutynin products do not infringe a patent for DITROPAN XL and ... -News-Medical.net

IMPAX Prevails in Alza's Appeal Related to Generic Version of ...  Sep 7, 2006
The suit alleged patent infringement related to IMPAX's filing of an Abbreviated New Drug Application (ANDA) for a generic version of Ditropan(R) XL ... -Genetic Engineering News

UPDATE 1-US court backs Mylan on generic incontinence drug  Sep 6, 2006
...the decision by the US District Court for the Northern District of West Virginia that Mylan's unique delivery system for the generic version of Ditropan XL did ... -Reuters

Mylan Says Appeals Court Upholds Oxybutynin Patent Ruling  Sep 7, 2006
...(MYL) said Thursday a federal appeals court has upheld a district court ruling that Mylan's Oxybutynin products do not infringe a patent for Ditropan XL, and ... -Easy Bourse (Communiqués de presse)

Mylan Awarded Positive Ruling In Oxybutynin Patent Litigation ...  Sep 7, 2006
The court confirmed the decision that the Oxybutynin products do not violate a patent for Ditropan XL and the patent is invalid. ... -Trading Markets

Mylan Wins Court Ruling In Patent Fight Vs J&J  Sep 6, 2006
The ruling could clear the way for the launch of generic versions of oxybutynin to treat over-active bladders, which J&J sells under the brand Ditropan. ... -Easy Bourse (Communiqués de presse)

Analysis: Mylan buys majority of Matrix  Aug 28, 2006
...'It also increases the importance, at least in our model, of (Mylan) being able to launch it`s generic version of Ditropan XL this fiscal year in order to make ... -Monsters and Critics.com

Health Highlights: Sept. 6, 2006  Sep 6, 2006
People taking any of the five drugs -- oxybutynin (Ditropan, Ditropan XL and Oxytrol, a skin patch); tolterodine (Detrol, Detrol LA); trospium (Sanctura ... -Forbes

Briefs: Wachovia joins forces with GE credit card venture  Sep 8, 2006
...said Thursday a US Court of Appeals ruled that the Pittsburgh-based generic drugmaker had not infringed on a patent for Ditropan XL with its generic Oxybutynin ... -Pittsburgh Tribune-Review

Tolterodine Extended-Release Does Not Impair Memory In Patients ...  -  Dec 1, 2006
Medical News Today,The results also showed, however, that oxybutynin chloride ER (Ditropan-XL®), 20 mg per day, reduced memory to the same degree as might be expected with 20

On Safety of 16 Drugs in Children  -  Nov 15, 2006
Wall Street Journal (subscription),...s cancer drug Gemzar, and Johnson & Johnson's Ditropan to treat bladder instability. The other eight drugs either presented new unlabeled safety concerns or

Analysis: Mylan buys majority of Matrix  29 Aug 2006
...'It also increases the importance, at least in our model, of (Mylan) being able to launch it`s generic version of Ditropan XL this fiscal year in order to make ... -Monsters and Critics.com

Survey Sheds Light On Mistaken Identities Of Interstitial Cystitis ...  Aug 20, 2006
...such as ORTHO EVRA® (norelgestromin/ethinyl estradiol transdermal system), ORTHO TRI-CYCLEN® LO (norgestimate/ethinyl estradiol), DITROPAN XL® (oxybutynin ... -Medical News Today

New Survey Sheds Light on Mistaken Identities of Interstitial ...  Aug 17, 2006
...products such as ORTHO EVRA(R) (norelgestromin/ethinyl estradiol transdermal system), ORTHO TRI-CYCLEN(R) LO (norgestimate/ethinyl estradiol), DITROPAN XL(R ... -Drug Newswire

Ortho Celebrates 75 Years of Partnering With Women  Jul 25, 2006
...and patients with products such as ORTHO EVRA(R) (norelgestromin/ethinyl estradiol), ORTHO TRI-CYCLEN(R) LO (norgestimate/ethinyl estradiol), DITROPAN XL(R ... -PR Newswire

Medications Can Make Heat More Dangerous  Jul 17, 2006
...and Tylenol PM. Diuretics, laxatives and bladder control medications such as Detrol and Ditropan can dehydrate you. If you take ... -NBC 10.com

Pharmacy: High temps make some sensitive to heat exhaustion  Jul 16, 2006
...medication. Someone taking a drug (Detrol or Ditropan) for urinary incontinence or overactive bladder is especially vulnerable. ... -Houston Chronicle

Urinary Incontinence Therapeutics Market Expected To Be Worth ...  Jul 5, 2006
...treatment in conjunction with other non therapeutic treatments such as physical exercises and surgical procedures; Pfizer's Detrol and Alza's Ditropan are the ... -Genetic Engineering News



CAN WATER TAKE WEIGHT OFF?  Apr 19, 2006
I recently began to take Ditropan XL at night, and it works well for me. ... SK. ANSWER: Ditropan XL (oxybutynin) calms overactive bladder muscles. ... - Charlotte Sun-Herald

Report Shows Popular Birth Control Pill, Ortho Tri-Cyclen(R) LO ...  May 11, 2006
...products such as ORTHO EVRA(R) (norelgestromin/ethinyl estradiol transdermal system), ORTHO TRI-CYCLEN(R) LO (norgestimate/ethinyl estradiol), DITROPAN XL(R ... - Medical News Today



What to do if you have an overactive bladder  Feb 6, 2006
...bladder to hold more urine. The medication that has been used for the longest time is oxybutynin (Ditropan). This originally came in ... - MSNBC

Neurologist's study of brain began with goldfish  Feb 22, 2006
...function. Common anticholinergic drugs are Detrol (tolterodine) and Ditropan (oxybutinin), which are used to treat overactive bladder. ... - CNN

Mylan: Generic Drugs, Premium Price  Feb 9, 2006
Of course, a pipeline is no guarantee -- for example, while the company is cleared to begin selling generic Ditropan XL fairly soon, it's still battling with ... - MSNBC

Results of Two Epidemiological Studies Provide Important New ...  Feb 16, 2006
...and patients with products such as ORTHO EVRA(R) (norelgestromin/ethinyl estradiol), ORTHO TRI-CYCLEN(R) LO (norgestimate/ethinyl estradiol), DITROPAN XL(R ... - International News Service,

Mylan: Generic Drugs, Premium Price  09 Feb 2006
Of course, a pipeline is no guarantee -- for example, while the company is cleared to begin selling generic Ditropan XL fairly soon, it's still battling with ... - MSNBC

What to do if you have an overactive bladder  Feb 6, 2006
...bladder to hold more urine. The medication that has been used for the longest time is oxybutynin (Ditropan). This originally came in ... - MSNBC

Mylan's Pipeline Not Compelling Enough  Feb 3, 2006
He also likes Ditropan XL, which Mylan will likely launch after an appellate court decision given the recent deal with Johnson & Johnson (nyse: JNJ - news ... - Forbes

High Expectations Sink Drug Stocks  Feb 4, 2006
...first-to-file" generic drug opportunities and highlighted generic versions of Pfizer's Norvasc and Johnson & Johnson's (nyse: JNJ - news - people ) Ditropan XL ... - Forbes

Next Five Years May Be 'Challenging' For J&J  Jan 30, 2006
These will be followed by generic threats to Concerta for attention deficit and hyperactivity disorder, Ditropan XL for overactive bladder, and, in Europe ... - Forbes

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional